AIM Investment Funds (Invesco Investment Funds). Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly and Co.LLY | 10.59% | $127.89M | 111,322 |
| Johnson & JohnsonJNJ | 6.76% | $81.64M | 318,485 |
| UnitedHealth Group Inc.UNH | 6.17% | $74.44M | 179,631 |
| Invesco Private Prime FundCash or money market | 4.67% | $56.33M | 56,329,199 |
| Merck & Co., Inc.MRK | 4.59% | $55.42M | 425,626 |
| AbbVie Inc.ABBV | 4.03% | $48.60M | 193,684 |
| Gilead Sciences, Inc.GILD | 3.63% | $43.88M | 337,004 |
| argenx SEARGX | 3.24% | $39.08M | 45,770 |
| CVS Health Corp.CVS | 2.52% | $30.42M | 291,313 |
| Welltower Inc.WELL | 2.34% | $28.24M | 120,441 |
| BrightSpring Health Services, Inc.BTSG | 2.20% | $26.55M | 444,597 |
| Royalty Pharma PLCRPRX | 2.13% | $25.77M | 440,990 |
| Cardinal Health, Inc.CAH | 2.10% | $25.34M | 110,152 |
| Guardant Health, Inc.GH | 2.04% | $24.65M | 152,178 |
| Vertex Pharmaceuticals Inc.VRTX | 2.01% | $24.31M | 50,958 |
| Invesco Private Government FundCash or money market | 1.80% | $21.70M | 21,699,976 |
| Axsome Therapeutics, Inc.AXSM | 1.58% | $19.12M | 87,700 |
| Edwards Lifesciences Corp.EW | 1.56% | $18.86M | 219,094 |
| Invesco Treasury PortfolioCash or money market | 1.56% | $18.83M | 18,825,670 |
| Thermo Fisher Scientific Inc.TMO | 1.55% | $18.74M | 32,631 |
| BridgeBio Pharma, Inc.BBIO | 1.43% | $17.32M | 216,227 |
| U C B S.A. | 1.24% | $17.24M | 58,259 |
| Sandoz Group AG | 1.14% | $17.06M | 169,209 |
| Waters Corp.WAT | 1.41% | $17.04M | 45,153 |
| IQVIA Holdings Inc.IQV | 1.32% | $15.93M | 67,768 |
| Ligand Pharmaceuticals Inc.LGND | 1.18% | $14.21M | 49,408 |
| Protagonist Therapeutics, Inc.PTGX | 1.18% | $14.20M | 103,952 |
| Natera, Inc.NTRA | 1.17% | $14.10M | 52,670 |
| Galderma Group AG | 0.90% | $13.38M | 49,726 |
| Ascendis Pharma A/S | 1.09% | $13.20M | 54,101 |
| Revolution Medicines, Inc.RVMD | 1.09% | $13.10M | 69,866 |
| Amgen Inc.AMGN | 1.07% | $12.87M | 33,407 |
| Halozyme Therapeutics, Inc.HALO | 1.06% | $12.80M | 155,098 |
| United Therapeutics Corp.UTHR | 0.99% | $11.93M | 23,038 |
| Quest Diagnostics Inc.DGX | 0.98% | $11.87M | 50,956 |
| Mettler-Toledo International Inc.MTD | 0.92% | $11.11M | 7,844 |
| Charles River Laboratories International, Inc.CRL | 0.92% | $11.05M | 47,533 |
| Intuitive Surgical, Inc.ISRG | 0.90% | $10.84M | 30,687 |
| Lonza Group AG | 0.71% | $10.54M | 12,228 |
| Medline Inc.MDLN | 0.86% | $10.40M | 264,708 |
| Madrigal Pharmaceuticals, Inc.MDGL | 0.82% | $9.89M | 21,162 |
| Invesco Government & Agency PortfolioCash or money market | 0.81% | $9.78M | 9,784,659 |
| AstraZeneca PLC | 0.79% | $9.53M | 56,196 |
| West Pharmaceutical Services, Inc.WST | 0.79% | $9.52M | 27,934 |
| Labcorp Holdings Inc.LH | 0.71% | $8.59M | 27,780 |
| Cytokinetics, Inc.CYTK | 0.69% | $8.32M | 107,839 |
| Tenet Healthcare Corp.THC | 0.67% | $8.03M | 31,528 |
| Steris PLCSTE | 0.63% | $7.56M | 33,121 |
| Krystal Biotech, Inc.KRYS | 0.57% | $6.94M | 20,337 |
| Arrowhead Pharmaceuticals, Inc.ARWR | 0.57% | $6.93M | 81,814 |